Vertex Pharmaceuticals (VRTX) Ivacaftor Monotherapy Showed Statistically Significant Improvements in Lung Function

July 29, 2013 4:07 PM

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the first clinical data from one of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found